-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Malignant Hematology

ASH-a-Palooza
Program: Trainee Activities and Services
Session: Blood Drop: Malignant Hematology
Friday, December 6, 2024, 2:40 PM-2:50 PM
Friday, December 6, 2024, 3:00 PM-3:10 PM

John C. Byrd, MD

Department of Internal Medicine, University of Cincinnati, Cincinnati, OH

Disclosures: Byrd: Vincerx Pharma, Eilean Therapeutics, and Kurome Therapeutics: Current equity holder in private company; Abbvie, AstraZeneca, and Syndax: Consultancy.

See more of: Blood Drop: Malignant Hematology
See more of: ASH-a-Palooza
See more of: Trainee Activities and Services